O	O	O	0	3	The	The	B-NP	DT	O	6	NMOD	O
T1	B-Entity	B-Entity	4	8	peri	peri	I-NP	AFX	O	6	NMOD	O
T1	I-Entity	I-Entity	8	9	-	-	I-NP	HYPH	O	6	NMOD	O
T1	I-Entity	I-Entity	9	14	kappa	kappa	I-NP	NN	B-DNA	6	NMOD	B-DNA
T1	I-Entity	I-Entity	15	16	B	B	I-NP	NN	I-DNA	6	NMOD	I-DNA
T1	I-Entity	I-Entity	17	21	site	site	I-NP	NN	I-DNA	7	SUB	I-DNA
O	O	O	22	30	mediates	mediate	B-VP	VBZ	O	0	ROOT	O
T2	B-Entity	B-Entity	31	36	human	human	B-NP	JJ	B-DNA	13	NMOD	B-DNA
T2	I-Entity	I-Entity	37	53	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	13	NMOD	I-DNA
T2	I-Entity	I-Entity	54	59	virus	virus	I-NP	NN	I-DNA	13	NMOD	I-DNA
T2	I-Entity	I-Entity	60	64	type	type	I-NP	NN	I-DNA	13	NMOD	I-DNA
T2	I-Entity	I-Entity	65	66	2	2	I-NP	CD	I-DNA	13	NMOD	I-DNA
T2	I-Entity	I-Entity	67	75	enhancer	enhancer	I-NP	NN	I-DNA	14	NMOD	I-DNA
O	O	O	76	86	activation	activation	I-NP	NN	O	7	OBJ	O
O	O	O	87	89	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	90	99	monocytes	monocyte	B-NP	NNS	B-cell_type	15	PMOD	B-cell_type
O	O	O	100	103	but	but	B-PP	CC	O	15	PMOD	O
O	O	O	104	107	not	not	B-PP	RB	O	19	PMOD	O
O	O	O	108	110	in	in	I-PP	IN	O	15	PMOD	O
O	O	O	111	112	T	T	B-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	O	113	118	cells	cell	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	O	118	119	.	.	O	.	O	7	P	O

O	O	O	121	126	Human	Human	B-NP	JJ	O	4	NMOD	O
O	O	O	127	143	immunodeficiency	immunodeficiency	I-NP	NN	O	4	NMOD	O
O	O	O	144	149	virus	virus	I-NP	NN	O	4	NMOD	O
O	O	O	150	154	type	type	I-NP	NN	O	17	SUB	O
O	O	O	155	156	2	2	I-NP	CD	O	4	NMOD	O
O	O	O	157	158	(	(	O	(	O	10	DEP	O
O	O	O	158	161	HIV	HIV	B-NP	NN	O	9	SUB	O
O	O	O	161	162	-	-	O	HYPH	O	9	P	O
O	O	O	162	163	2	2	B-NP	CD	O	10	DEP	O
O	O	O	163	164	)	)	O	)	O	4	NMOD	O
O	O	O	164	165	,	,	O	,	O	4	P	O
O	O	O	166	170	like	like	B-PP	IN	O	4	NMOD	O
O	O	O	171	174	HIV	HIV	B-NP	NN	O	15	NMOD	O
O	O	O	174	175	-	-	B-NP	HYPH	O	15	P	O
O	O	O	175	176	1	1	I-NP	CD	O	12	PMOD	O
O	O	O	176	177	,	,	O	,	O	4	P	O
O	O	O	178	184	causes	cause	B-VP	VBZ	O	0	ROOT	O
O	O	O	185	189	AIDS	AIDS	B-NP	NN	O	17	OBJ	O
O	O	O	190	193	and	and	O	CC	O	17	VMOD	O
O	O	O	194	196	is	be	B-VP	VBZ	O	17	VMOD	O
O	O	O	197	207	associated	associate	I-VP	VBN	O	20	VC	O
O	O	O	208	212	with	with	B-PP	IN	O	21	VMOD	O
O	O	O	213	217	AIDS	AIDS	B-NP	NN	O	24	NMOD	O
O	O	O	218	223	cases	case	I-NP	NNS	O	22	PMOD	O
O	O	O	224	233	primarily	primarily	B-ADVP	RB	O	24	NMOD	O
O	O	O	234	236	in	in	B-PP	IN	O	24	NMOD	O
O	O	O	237	241	West	West	B-NP	NNP	O	28	NMOD	O
O	O	O	242	248	Africa	Africa	I-NP	NNP	O	26	PMOD	O
O	O	O	248	249	.	.	O	.	O	17	P	O

O	O	O	250	253	HIV	HIV	B-NP	NN	O	0	ROOT	O
O	O	O	253	254	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	O	254	255	1	1	I-NP	CD	O	7	NMOD	O
O	O	O	256	259	and	and	I-NP	CC	O	7	NMOD	O
O	O	O	260	263	HIV	HIV	I-NP	NN	O	7	NMOD	O
O	O	O	263	264	-	-	O	HYPH	O	7	P	O
O	O	O	264	265	2	2	B-NP	CD	O	8	SUB	O
O	O	O	266	273	display	display	B-VP	VBP	O	1	NMOD	O
O	O	O	274	285	significant	significant	B-NP	JJ	O	10	NMOD	O
O	O	O	286	297	differences	difference	I-NP	NNS	O	8	OBJ	O
O	O	O	298	300	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	301	308	nucleic	nucleic	B-NP	JJ	O	14	NMOD	O
O	O	O	309	313	acid	acid	I-NP	NN	O	14	NMOD	O
O	O	O	314	322	sequence	sequence	I-NP	NN	O	11	PMOD	O
O	O	O	323	326	and	and	B-PP	CC	O	11	PMOD	O
O	O	O	327	329	in	in	B-PP	IN	O	11	PMOD	O
O	O	O	330	333	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	334	341	natural	natural	I-NP	JJ	O	19	NMOD	O
O	O	O	342	349	history	history	I-NP	NN	O	16	PMOD	O
O	O	O	350	352	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	353	361	clinical	clinical	B-NP	JJ	O	22	NMOD	O
O	O	O	362	369	disease	disease	I-NP	NN	O	20	PMOD	O
O	O	O	369	370	.	.	O	.	O	1	P	O

O	O	O	371	381	Consistent	Consistent	B-ADJP	JJ	O	7	VMOD	O
O	O	O	382	386	with	with	B-PP	IN	O	1	AMOD	O
O	O	O	387	392	these	these	B-NP	DT	O	4	NMOD	O
O	O	O	393	404	differences	difference	I-NP	NNS	O	2	PMOD	O
O	O	O	404	405	,	,	O	,	O	7	P	O
O	O	O	406	408	we	we	B-NP	PRP	O	7	SUB	O
O	O	O	409	413	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	414	424	previously	previously	I-VP	RB	O	7	VMOD	O
O	O	O	425	437	demonstrated	demonstrate	I-VP	VBN	O	7	VC	O
O	O	O	438	442	that	that	B-SBAR	IN	O	9	VMOD	O
O	O	O	443	446	the	the	B-NP	DT	O	15	NMOD	O
T3	B-Entity	B-Entity	447	455	enhancer	enhancer	I-NP	NN	B-DNA	15	NMOD	B-DNA
T3	I-Entity	I-Entity	455	456	/	/	B-NP	SYM	I-DNA	15	NMOD	I-DNA
T3	I-Entity	I-Entity	456	464	promoter	promoter	I-NP	NN	I-DNA	15	NMOD	I-DNA
T3	I-Entity	I-Entity	465	471	region	region	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	O	472	474	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	475	478	HIV	HIV	B-NP	NN	O	16	PMOD	O
O	O	O	478	479	-	-	O	HYPH	O	20	P	O
O	O	O	479	480	2	2	B-NP	CD	O	20	NMOD	O
O	O	O	481	490	functions	function	I-NP	NNS	O	10	SBAR	O
O	O	O	491	496	quite	quite	B-ADVP	RB	O	20	VMOD	O
O	O	O	497	508	differently	differently	I-ADVP	RB	O	21	AMOD	O
O	O	O	509	513	from	from	B-PP	IN	O	21	AMOD	O
O	O	O	514	518	that	that	B-NP	DT	O	23	PMOD	O
O	O	O	519	521	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	522	525	HIV	HIV	B-NP	NN	O	25	PMOD	O
O	O	O	525	526	-	-	B-NP	HYPH	O	26	P	O
O	O	O	526	527	1	1	I-NP	CD	O	26	NMOD	O
O	O	O	527	528	.	.	O	.	O	7	P	O

O	O	O	529	536	Whereas	Whereas	B-PP	IN	O	54	VMOD	O
O	O	O	537	547	activation	activation	B-NP	NN	O	14	SUB	O
O	O	O	548	550	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	551	554	the	the	B-NP	DT	O	8	NMOD	O
T4	B-Entity	B-Entity	555	558	HIV	HIV	I-NP	NN	B-DNA	8	NMOD	B-DNA
T4	I-Entity	I-Entity	558	559	-	-	B-NP	HYPH	I-DNA	8	NMOD	I-DNA
T4	I-Entity	I-Entity	559	560	1	1	I-NP	CD	I-DNA	8	NMOD	I-DNA
T4	I-Entity	I-Entity	561	569	enhancer	enhancer	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	O	570	579	following	follow	B-PP	VBG	O	2	NMOD	O
O	O	O	580	581	T	T	B-NP	NN	O	13	NMOD	O
O	O	O	581	582	-	-	I-NP	HYPH	O	13	NMOD	O
O	O	O	582	586	cell	cell	I-NP	NN	O	13	NMOD	O
O	O	O	587	598	stimulation	stimulation	I-NP	NN	O	9	PMOD	O
O	O	O	599	601	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	O	602	610	mediated	mediate	I-VP	VBN	O	14	VC	O
O	O	O	611	618	largely	largely	B-ADVP	RB	O	15	VMOD	O
O	O	O	619	626	through	through	B-PP	IN	O	15	VMOD	O
O	O	O	627	634	binding	binding	B-NP	NN	O	17	PMOD	O
O	O	O	635	637	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	638	641	the	the	B-NP	DT	O	22	NMOD	O
T5	B-Entity	B-Entity	642	655	transcription	transcription	I-NP	NN	B-protein	22	NMOD	B-protein
T5	I-Entity	I-Entity	656	662	factor	factor	I-NP	NN	I-protein	26	NMOD	I-protein
T6	I-Entity	I-Entity	663	665	NF	NF	I-NP	NN	B-protein	26	NMOD	B-protein
T6	I-Entity	I-Entity	665	666	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T6	I-Entity	I-Entity	666	671	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T6	I-Entity	I-Entity	672	673	B	B	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	O	674	676	to	to	B-PP	TO	O	18	NMOD	O
O	O	O	677	680	two	two	B-NP	CD	O	27	PMOD	O
O	O	O	681	689	adjacent	adjacent	I-NP	JJ	O	28	NMOD	O
T7,T8	B-Entity,B-Entity	B-Entity,B-Entity	690	695	kappa	kappa	I-NP	NN	B-DNA	32	NMOD	B-DNA
T7,T8	I-Entity,I-Entity	I-Entity,I-Entity	696	697	B	B	I-NP	NN	I-DNA	32	NMOD	I-DNA
T7	I-Entity	I-Entity	698	703	sites	site	I-NP	NNS	I-DNA	28	NMOD	I-DNA
T7	I-Entity	I-Entity	704	706	in	in	B-PP	IN	O	28	NMOD	O
T7	I-Entity	I-Entity	707	710	the	the	B-NP	DT	O	40	NMOD	O
T7,T9	I-Entity,B-Entity	I-Entity,B-Entity	711	714	HIV	HIV	I-NP	NN	B-DNA	40	NMOD	B-DNA
T7,T9	I-Entity,I-Entity	I-Entity,I-Entity	714	715	-	-	B-NP	HYPH	I-DNA	40	NMOD	I-DNA
T7,T9	I-Entity,I-Entity	I-Entity,I-Entity	715	716	1	1	I-NP	CD	I-DNA	40	NMOD	I-DNA
T7,T9	I-Entity,I-Entity	I-Entity,I-Entity	717	721	long	long	I-NP	JJ	I-DNA	40	NMOD	I-DNA
T7,T9	I-Entity,I-Entity	I-Entity,I-Entity	722	730	terminal	terminal	I-NP	JJ	I-DNA	40	NMOD	I-DNA
T7,T9	I-Entity,I-Entity	I-Entity,I-Entity	731	737	repeat	repeat	I-NP	NN	I-DNA	33	PMOD	I-DNA
O	O	O	737	738	,	,	O	,	O	54	P	O
O	O	O	739	749	activation	activation	B-NP	NN	O	54	SUB	O
O	O	O	750	752	of	of	B-PP	IN	O	42	NMOD	O
O	O	O	753	756	the	the	B-NP	DT	O	48	NMOD	O
T10	B-Entity	B-Entity	757	760	HIV	HIV	I-NP	NN	B-DNA	48	NMOD	B-DNA
T10	I-Entity	I-Entity	760	761	-	-	I-NP	HYPH	I-DNA	48	NMOD	I-DNA
T10	I-Entity	I-Entity	761	762	2	2	I-NP	CD	I-DNA	48	NMOD	I-DNA
T10	I-Entity	I-Entity	763	771	enhancer	enhancer	I-NP	NN	I-DNA	43	PMOD	I-DNA
O	O	O	772	774	in	in	B-PP	IN	O	42	NMOD	O
O	O	O	775	784	monocytes	monocyte	B-NP	NNS	B-cell_type	53	NMOD	B-cell_type
O	O	O	785	788	and	and	O	CC	O	53	NMOD	O
O	O	O	789	790	T	T	B-NP	NN	B-cell_type	53	NMOD	B-cell_type
O	O	O	791	796	cells	cell	B-NP	NNS	I-cell_type	49	PMOD	I-cell_type
O	O	O	797	799	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	800	809	dependent	dependent	B-ADJP	JJ	O	54	PRD	O
O	O	O	810	812	on	on	B-PP	IN	O	55	AMOD	O
O	O	O	813	817	four	four	B-NP	CD	O	56	PMOD	O
T11	B-Entity	B-Entity	818	821	cis	cis	I-NP	NN	B-DNA	61	NMOD	B-DNA
T11	I-Entity	I-Entity	821	822	-	-	O	HYPH	I-DNA	58	P	I-DNA
T11	I-Entity	I-Entity	822	828	acting	act	B-VP	VBG	I-DNA	61	NMOD	I-DNA
T11	I-Entity	I-Entity	829	837	elements	element	B-NP	NNS	I-DNA	57	NMOD	I-DNA
O	O	O	837	838	:	:	O	:	O	54	P	O
O	O	O	839	840	a	a	B-NP	DT	O	67	NMOD	O
O	O	O	841	847	single	single	I-NP	JJ	O	67	NMOD	O
T12	B-Entity	B-Entity	848	853	kappa	kappa	I-NP	NN	B-DNA	67	NMOD	B-DNA
T12	I-Entity	I-Entity	854	855	B	B	I-NP	NN	I-DNA	67	NMOD	I-DNA
T12	I-Entity	I-Entity	856	860	site	site	I-NP	NN	I-DNA	78	NMOD	I-DNA
O	O	O	860	861	,	,	O	,	O	78	P	O
O	O	O	862	865	two	two	B-NP	CD	O	74	NMOD	O
T13	B-Entity	B-Entity	866	872	purine	purine	I-NP	NN	B-DNA	74	NMOD	B-DNA
T13	I-Entity	I-Entity	872	873	-	-	O	HYPH	I-DNA	74	NMOD	I-DNA
T13	I-Entity	I-Entity	873	877	rich	rich	B-NP	JJ	I-DNA	74	NMOD	I-DNA
T13	I-Entity	I-Entity	878	885	binding	bind	I-NP	VBG	I-DNA	74	NMOD	I-DNA
T13	I-Entity	I-Entity	886	891	sites	site	I-NP	NNS	I-DNA	78	NMOD	I-DNA
O	O	O	891	892	,	,	O	,	O	78	P	O
T14	B-Entity	B-Entity	893	897	PuB1	PuB1	B-NP	NN	B-DNA	78	NMOD	B-DNA
O	O	O	898	901	and	and	I-NP	CC	O	78	NMOD	O
T15	B-Entity	B-Entity	902	906	PuB2	PuB2	I-NP	NN	B-DNA	83	NMOD	B-DNA
O	O	O	906	907	,	,	O	,	O	83	P	O
O	O	O	908	911	and	and	O	CC	O	83	NMOD	O
O	O	O	912	913	a	a	B-NP	DT	O	83	NMOD	O
T16	B-Entity	B-Entity	914	918	pets	pet	I-NP	NNS	B-DNA	83	NMOD	B-DNA
T16	I-Entity	I-Entity	919	923	site	site	I-NP	NN	I-DNA	54	VMOD	I-DNA
O	O	O	923	924	.	.	O	.	O	54	P	O

O	O	O	925	927	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	928	932	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	933	936	now	now	I-VP	RB	O	2	VMOD	O
O	O	O	937	947	identified	identify	I-VP	VBN	O	2	VC	O
O	O	O	948	949	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	950	955	novel	novel	I-NP	JJ	O	10	NMOD	O
T17	B-Entity	B-Entity	956	959	cis	cis	I-NP	NN	B-DNA	10	NMOD	B-DNA
T17	I-Entity	I-Entity	959	960	-	-	B-PP	HYPH	I-DNA	10	NMOD	I-DNA
T17	I-Entity	I-Entity	960	966	acting	act	B-NP	VBG	I-DNA	10	NMOD	I-DNA
T17	I-Entity	I-Entity	967	974	element	element	I-NP	NN	I-DNA	4	OBJ	I-DNA
O	O	O	975	981	within	within	B-PP	IN	O	10	NMOD	O
O	O	O	982	985	the	the	B-NP	DT	O	16	NMOD	O
T18	B-Entity	B-Entity	986	989	HIV	HIV	I-NP	NN	B-DNA	16	NMOD	B-DNA
T18	I-Entity	I-Entity	989	990	-	-	I-NP	HYPH	I-DNA	16	NMOD	I-DNA
T18	I-Entity	I-Entity	990	991	2	2	I-NP	CD	I-DNA	16	NMOD	I-DNA
T18	I-Entity	I-Entity	992	1000	enhancer	enhancer	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	1000	1001	,	,	O	,	O	10	P	O
O	O	O	1002	1013	immediately	immediately	B-ADJP	RB	O	10	NMOD	O
O	O	O	1014	1022	upstream	upstream	I-ADJP	JJ	O	18	AMOD	O
O	O	O	1023	1025	of	of	B-PP	IN	O	18	AMOD	O
O	O	O	1026	1029	the	the	B-NP	DT	O	24	NMOD	O
T19	B-Entity	B-Entity	1030	1035	kappa	kappa	I-NP	NN	B-DNA	24	NMOD	B-DNA
T19	I-Entity	I-Entity	1036	1037	B	B	I-NP	NN	I-DNA	24	NMOD	I-DNA
T19	I-Entity	I-Entity	1038	1042	site	site	I-NP	NN	I-DNA	20	PMOD	I-DNA
O	O	O	1042	1043	,	,	O	,	O	10	P	O
O	O	O	1044	1054	designated	designate	B-VP	VBN	O	10	NMOD	O
T20	B-Entity	B-Entity	1055	1059	peri	peri	B-NP	AFX	B-protein	30	NMOD	B-protein
T20	I-Entity	I-Entity	1059	1060	-	-	I-NP	HYPH	I-protein	30	NMOD	I-protein
T20	I-Entity	I-Entity	1060	1065	kappa	kappa	I-NP	NN	I-protein	30	NMOD	I-protein
T20	I-Entity	I-Entity	1066	1067	B	B	I-NP	NN	I-protein	26	VMOD	I-protein
O	O	O	1067	1068	.	.	O	.	O	2	P	O

O	O	O	1069	1073	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	1074	1078	site	site	I-NP	NN	O	3	SUB	O
O	O	O	1079	1081	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1082	1091	conserved	conserve	I-VP	VBN	O	3	VC	O
O	O	O	1092	1097	among	among	B-PP	IN	O	4	VMOD	O
O	O	O	1098	1106	isolates	isolate	B-NP	NNS	O	5	PMOD	O
O	O	O	1107	1109	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	1110	1113	HIV	HIV	B-NP	NN	O	7	PMOD	O
O	O	O	1113	1114	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	1114	1115	2	2	I-NP	CD	O	9	NMOD	O
O	O	O	1116	1119	and	and	O	CC	O	3	VMOD	O
O	O	O	1120	1123	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	1124	1131	closely	closely	I-NP	RB	O	14	AMOD	O
O	O	O	1132	1139	related	related	I-NP	JJ	O	17	NMOD	O
O	O	O	1140	1146	simian	simian	I-NP	JJ	O	17	NMOD	O
O	O	O	1147	1163	immunodeficiency	immunodeficiency	I-NP	NN	O	17	NMOD	O
O	O	O	1164	1169	virus	virus	I-NP	NN	O	22	SUB	O
O	O	O	1169	1170	,	,	O	,	O	22	P	O
O	O	O	1171	1174	and	and	O	CC	O	22	VMOD	O
O	O	O	1175	1187	transfection	transfection	B-NP	NN	O	21	NMOD	O
O	O	O	1188	1194	assays	assay	I-NP	NNS	O	22	SUB	O
O	O	O	1195	1199	show	show	B-VP	VBP	O	11	SBAR	O
O	O	O	1200	1204	this	this	B-NP	DT	O	24	NMOD	O
O	O	O	1205	1209	site	site	I-NP	NN	O	22	OBJ	O
O	O	O	1210	1212	to	to	B-VP	TO	O	26	VMOD	O
O	O	O	1213	1220	mediate	mediate	I-VP	VB	O	24	NMOD	O
T21	B-Entity	B-Entity	1221	1224	HIV	HIV	B-NP	NN	B-DNA	30	NMOD	B-DNA
T21	I-Entity	I-Entity	1224	1225	-	-	B-NP	HYPH	I-DNA	30	NMOD	I-DNA
T21	I-Entity	I-Entity	1225	1226	2	2	I-NP	CD	I-DNA	30	NMOD	I-DNA
T21	I-Entity	I-Entity	1227	1235	enhancer	enhancer	I-NP	NN	I-DNA	31	NMOD	I-DNA
O	O	O	1236	1246	activation	activation	I-NP	NN	O	26	OBJ	O
O	O	O	1247	1256	following	follow	B-PP	VBG	O	26	VMOD	O
O	O	O	1257	1268	stimulation	stimulation	B-NP	NN	O	32	PMOD	O
O	O	O	1269	1271	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	1272	1281	monocytic	monocytic	B-NP	JJ	O	41	NMOD	O
O	O	O	1282	1285	but	but	B-NP	CC	O	41	NMOD	O
O	O	O	1286	1289	not	not	I-NP	RB	O	36	DEP	O
O	O	O	1290	1291	T	T	B-NP	NN	B-cell_line	41	NMOD	B-cell_line
O	O	O	1291	1292	-	-	B-NP	HYPH	I-cell_line	41	NMOD	I-cell_line
O	O	O	1292	1296	cell	cell	I-NP	NN	I-cell_line	41	NMOD	I-cell_line
O	O	O	1297	1302	lines	line	I-NP	NNS	I-cell_line	34	PMOD	I-cell_line
O	O	O	1302	1303	.	.	O	.	O	3	P	O

O	O	O	1304	1308	This	This	B-NP	DT	O	2	SUB	O
O	O	O	1309	1311	is	be	B-VP	VBZ	O	24	VMOD	O
O	O	O	1312	1315	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1316	1321	first	first	I-NP	JJ	O	5	NMOD	O
O	O	O	1322	1333	description	description	I-NP	NN	O	2	PRD	O
O	O	O	1334	1336	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1337	1339	an	an	B-NP	DT	O	12	NMOD	O
T22	B-Entity	B-Entity	1340	1343	HIV	HIV	I-NP	NN	B-DNA	12	NMOD	B-DNA
T22	I-Entity	I-Entity	1343	1344	-	-	I-NP	HYPH	I-DNA	12	NMOD	I-DNA
T22	I-Entity	I-Entity	1344	1345	2	2	I-NP	CD	I-DNA	12	NMOD	I-DNA
T22	I-Entity	I-Entity	1346	1354	enhancer	enhancer	I-NP	NN	I-DNA	12	NMOD	I-DNA
T22	I-Entity	I-Entity	1355	1362	element	element	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	O	1363	1368	which	which	B-NP	WDT	O	12	NMOD	O
O	O	O	1369	1377	displays	display	B-VP	VBZ	O	13	SBAR	O
O	O	O	1378	1382	such	such	B-NP	JJ	O	17	NMOD	O
O	O	O	1383	1391	monocyte	monocyte	I-NP	NN	O	17	NMOD	O
O	O	O	1392	1403	specificity	specificity	I-NP	NN	O	14	OBJ	O
O	O	O	1403	1404	,	,	O	,	O	24	P	O
O	O	O	1405	1408	and	and	O	CC	O	24	VMOD	O
O	O	O	1409	1411	no	no	B-NP	DT	O	21	NMOD	O
O	O	O	1412	1422	comparable	comparable	I-NP	JJ	O	24	SUB	O
T23	B-Entity	B-Entity	1423	1431	enhancer	enhancer	I-NP	NN	B-DNA	23	NMOD	B-DNA
T23	I-Entity	I-Entity	1432	1439	element	element	I-NP	NN	I-DNA	21	NMOD	I-DNA
O	O	O	1440	1443	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	1444	1448	been	be	I-VP	VBN	O	24	VC	O
O	O	O	1449	1456	clearly	clearly	I-VP	RB	O	25	VMOD	O
O	O	O	1457	1464	defined	define	I-VP	VBN	O	25	VC	O
O	O	O	1465	1468	for	for	B-PP	IN	O	27	VMOD	O
O	O	O	1469	1472	HIV	HIV	B-NP	NN	O	28	PMOD	O
O	O	O	1472	1473	-	-	B-NP	HYPH	O	29	P	O
O	O	O	1473	1474	1	1	I-NP	CD	O	29	NMOD	O
O	O	O	1474	1475	.	.	O	.	O	24	P	O

O	O	O	1476	1481	While	While	B-SBAR	IN	O	28	VMOD	O
O	O	O	1482	1483	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	1484	1491	nuclear	nuclear	I-NP	JJ	B-protein	6	NMOD	B-protein
O	O	O	1492	1498	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	1498	1499	(	(	I-NP	(	O	6	NMOD	O
O	O	O	1499	1500	s	s	I-NP	NNS	O	16	SUB	O
O	O	O	1500	1501	)	)	O	)	O	6	NMOD	O
O	O	O	1502	1506	from	from	B-PP	IN	O	6	NMOD	O
O	O	O	1507	1511	both	both	B-NP	CC	O	15	NMOD	O
O	O	O	1512	1522	peripheral	peripheral	I-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	O	1523	1528	blood	blood	I-NP	NN	I-cell_type	12	NMOD	I-cell_type
O	O	O	1529	1538	monocytes	monocyte	I-NP	NNS	I-cell_type	15	NMOD	I-cell_type
O	O	O	1539	1542	and	and	O	CC	O	15	NMOD	O
O	O	O	1543	1544	T	T	B-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	O	1545	1550	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	O	1551	1556	binds	bind	B-VP	VBZ	O	1	SBAR	O
O	O	O	1557	1560	the	the	B-NP	DT	O	22	NMOD	O
T24	B-Entity	B-Entity	1561	1565	peri	peri	I-NP	AFX	B-DNA	22	NMOD	B-DNA
T24	I-Entity	I-Entity	1565	1566	-	-	I-NP	HYPH	I-DNA	22	NMOD	I-DNA
T24	I-Entity	I-Entity	1566	1571	kappa	kappa	I-NP	NN	I-DNA	22	NMOD	I-DNA
T24	I-Entity	I-Entity	1572	1573	B	B	I-NP	NN	I-DNA	22	NMOD	I-DNA
T24	I-Entity	I-Entity	1574	1578	site	site	I-NP	NN	I-DNA	16	OBJ	I-DNA
O	O	O	1578	1579	,	,	O	,	O	28	P	O
O	O	O	1580	1595	electrophoretic	electrophoretic	B-NP	JJ	O	27	NMOD	O
O	O	O	1596	1604	mobility	mobility	I-NP	NN	O	27	NMOD	O
O	O	O	1605	1610	shift	shift	I-NP	NN	O	27	NMOD	O
O	O	O	1611	1617	assays	assay	I-NP	NNS	O	28	SUB	O
O	O	O	1618	1625	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1626	1630	that	that	B-SBAR	IN	O	44	DEP	O
O	O	O	1631	1637	either	either	O	CC	O	33	NMOD	O
O	O	O	1638	1639	a	a	B-NP	DT	O	33	NMOD	O
O	O	O	1640	1649	different	different	I-NP	JJ	O	33	NMOD	O
O	O	O	1650	1657	protein	protein	I-NP	NN	O	34	SUB	O
O	O	O	1658	1663	binds	bind	B-VP	VBZ	O	29	SBAR	O
O	O	O	1664	1666	to	to	B-PP	TO	O	34	VMOD	O
O	O	O	1667	1671	this	this	B-NP	DT	O	37	NMOD	O
O	O	O	1672	1676	site	site	I-NP	NN	O	35	PMOD	O
O	O	O	1677	1679	in	in	B-PP	IN	O	37	NMOD	O
O	O	O	1680	1689	monocytes	monocyte	B-NP	NNS	B-cell_type	42	NMOD	B-cell_type
O	O	O	1690	1696	versus	versus	B-PP	IN	O	42	NMOD	O
O	O	O	1697	1698	T	T	B-NP	NN	B-cell_type	42	NMOD	B-cell_type
O	O	O	1699	1704	cells	cell	I-NP	NNS	I-cell_type	38	PMOD	I-cell_type
O	O	O	1705	1707	or	or	O	CC	O	44	DEP	O
O	O	O	1708	1712	that	that	B-SBAR	IN	O	28	VMOD	O
O	O	O	1713	1716	the	the	B-NP	DT	O	46	NMOD	O
O	O	O	1717	1724	protein	protein	I-NP	NN	O	51	SUB	O
O	O	O	1725	1736	recognizing	recognize	B-VP	VBG	O	46	NMOD	O
O	O	O	1737	1741	this	this	B-NP	DT	O	50	NMOD	O
T25	B-Entity	B-Entity	1742	1750	enhancer	enhancer	I-NP	NN	B-DNA	50	NMOD	B-DNA
T25	I-Entity	I-Entity	1751	1758	element	element	I-NP	NN	I-DNA	47	OBJ	I-DNA
O	O	O	1759	1768	undergoes	undergo	B-VP	VBZ	O	44	SBAR	O
O	O	O	1769	1781	differential	differential	B-NP	JJ	O	53	NMOD	O
O	O	O	1782	1794	modification	modification	I-NP	NN	O	51	OBJ	O
O	O	O	1795	1797	in	in	B-PP	IN	O	53	NMOD	O
O	O	O	1798	1807	monocytes	monocyte	B-NP	NNS	B-cell_type	58	NMOD	B-cell_type
O	O	O	1808	1811	and	and	O	CC	O	58	NMOD	O
O	O	O	1812	1813	T	T	B-NP	NN	B-cell_type	58	NMOD	B-cell_type
O	O	O	1814	1819	cells	cell	I-NP	NNS	I-cell_type	54	PMOD	I-cell_type
O	O	O	1819	1820	,	,	O	,	O	28	P	O
O	O	O	1821	1825	thus	thus	B-ADVP	RB	O	61	VMOD	O
O	O	O	1826	1836	supporting	support	B-VP	VBG	O	28	VMOD	O
O	O	O	1837	1840	the	the	B-NP	DT	O	64	NMOD	O
O	O	O	1841	1853	transfection	transfection	I-NP	NN	O	64	NMOD	O
O	O	O	1854	1858	data	datum	I-NP	NNS	O	61	OBJ	O
O	O	O	1858	1859	.	.	O	.	O	28	P	O

O	O	O	1860	1867	Further	Further	B-ADVP	RB	O	23	VMOD	O
O	O	O	1867	1868	,	,	O	,	O	23	P	O
O	O	O	1869	1874	while	while	B-SBAR	IN	O	23	VMOD	O
O	O	O	1875	1883	specific	specific	B-NP	JJ	O	6	NMOD	O
O	O	O	1884	1896	constitutive	constitutive	I-NP	JJ	O	6	NMOD	O
O	O	O	1897	1904	binding	binding	I-NP	NN	O	14	SUB	O
O	O	O	1905	1907	to	to	B-PP	TO	O	6	NMOD	O
O	O	O	1908	1911	the	the	B-NP	DT	O	13	NMOD	O
T26	B-Entity	B-Entity	1912	1916	peri	peri	I-NP	AFX	B-DNA	13	NMOD	B-DNA
T26	I-Entity	I-Entity	1916	1917	-	-	I-NP	HYPH	I-DNA	13	NMOD	I-DNA
T26	I-Entity	I-Entity	1917	1922	kappa	kappa	I-NP	NN	I-DNA	13	NMOD	I-DNA
T26	I-Entity	I-Entity	1923	1924	B	B	I-NP	NN	I-DNA	13	NMOD	I-DNA
T26	I-Entity	I-Entity	1925	1929	site	site	I-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	O	1930	1932	is	be	B-VP	VBZ	O	3	SBAR	O
O	O	O	1933	1937	seen	see	I-VP	VBN	O	14	VC	O
O	O	O	1938	1940	in	in	B-PP	IN	O	15	VMOD	O
O	O	O	1941	1950	monocytes	monocyte	B-NP	NNS	B-cell_type	16	PMOD	B-cell_type
O	O	O	1950	1951	,	,	O	,	O	23	P	O
O	O	O	1952	1963	stimulation	stimulation	B-NP	NN	O	23	SUB	O
O	O	O	1964	1968	with	with	B-PP	IN	O	19	NMOD	O
O	O	O	1969	1976	phorbol	phorbol	B-NP	NN	O	22	NMOD	O
O	O	O	1977	1983	esters	ester	I-NP	NNS	O	20	PMOD	O
O	O	O	1984	1991	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	O	1992	2002	additional	additional	B-NP	JJ	O	26	AMOD	O
O	O	O	2002	2003	,	,	I-NP	,	O	26	P	O
O	O	O	2004	2012	specific	specific	I-NP	JJ	O	27	NMOD	O
O	O	O	2013	2020	binding	binding	I-NP	NN	O	23	OBJ	O
O	O	O	2020	2021	.	.	O	.	O	23	P	O

O	O	O	2022	2035	Understanding	Understand	B-VP	VBG	O	14	SUB	O
O	O	O	2036	2039	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	2040	2048	monocyte	monocyte	I-NP	NN	B-cell_type	6	NMOD	B-cell_type
O	O	O	2048	2049	-	-	B-NP	HYPH	O	6	NMOD	O
O	O	O	2049	2057	specific	specific	I-NP	JJ	O	6	NMOD	O
O	O	O	2058	2066	function	function	I-NP	NN	O	1	OBJ	O
O	O	O	2067	2069	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	2070	2073	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	2074	2078	peri	peri	I-NP	AFX	B-protein	13	NMOD	B-protein
O	O	O	2078	2079	-	-	I-NP	HYPH	I-protein	13	NMOD	I-protein
O	O	O	2079	2084	kappa	kappa	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	2085	2086	B	B	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	2087	2093	factor	factor	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	2094	2097	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	2098	2108	ultimately	ultimately	I-VP	RB	O	14	VMOD	O
O	O	O	2109	2116	provide	provide	I-VP	VB	O	14	VC	O
O	O	O	2117	2124	insight	insight	B-NP	NN	O	16	OBJ	O
O	O	O	2125	2129	into	into	B-PP	IN	O	17	NMOD	O
O	O	O	2130	2133	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	2134	2143	different	different	I-NP	JJ	O	25	NMOD	O
O	O	O	2144	2148	role	role	I-NP	NN	O	22	NMOD	O
O	O	O	2149	2158	monocytes	monocyte	I-NP	NNS	B-cell_type	25	NMOD	B-cell_type
O	O	O	2159	2162	and	and	O	CC	O	25	NMOD	O
O	O	O	2163	2164	T	T	B-NP	NN	B-cell_type	25	NMOD	B-cell_type
O	O	O	2165	2170	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	O	2171	2175	play	play	B-VP	VBP	O	16	VMOD	O
O	O	O	2176	2178	in	in	B-PP	IN	O	26	VMOD	O
O	O	O	2179	2182	HIV	HIV	B-NP	NN	O	29	NMOD	O
O	O	O	2183	2195	pathogenesis	pathogenesis	I-NP	NN	O	27	PMOD	O
O	O	O	2195	2196	.	.	O	.	O	14	P	O
